Earnings Per Share, Basic in USD/shares of Xilio Therapeutics, Inc. from Q3 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Xilio Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q3 2020 to Q3 2025.
  • Xilio Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.11 USD/shares, a 50% increase year-over-year.
  • Xilio Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 0 USD/shares, a 73.3% increase year-over-year.
  • Xilio Therapeutics, Inc. annual Earnings Per Share, Basic for 2024 was -1.09 USD/shares, a 60.8% increase from 2023.
  • Xilio Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.78 USD/shares, a 13.7% increase from 2022.
  • Xilio Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -3.22 USD/shares, a 76.2% increase from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Xilio Therapeutics, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $0 $0 +$0.11 +50% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $0 $0 +$0.08 +33.3% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $0 $0 +$0.44 +71% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$1 $0 +$0.63 +98.4% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025
Q3 2024 -$1 $0 +$0.39 +63.9% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$2 $0 +$0.46 +65.7% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$2 -$1 +$0.21 +25.3% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$2 -$1 +$0.18 +22% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 -$2 -$1 +$0.11 +15.3% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$3 -$1 +$0.20 +22.2% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 -$3 -$1 $0 -6.41% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 -$3 -$1 -$64 -101% 01 Oct 2022 31 Dec 2022 10-K 01 Apr 2024
Q3 2022 $60.00 -$1 +$20.60 +96.6% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $39.00 -$1 +$30.60 +97.1% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 $9.00 -$1 +$22.80 +96.7% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$13 $62.80 01 Oct 2021 31 Dec 2021 10-K 02 Mar 2023
Q3 2021 -$21 +$2.92 +12.1% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$32 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 -$24 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q3 2020 -$24 01 Jul 2020 30 Sep 2020 10-Q 02 Dec 2021

Xilio Therapeutics, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1 +$1.69 +60.8% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 -$3 +$0.44 +13.7% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 -$3 +$10.30 +76.2% 01 Jan 2022 31 Dec 2022 10-K 01 Apr 2024
2021 -$14 +$91.90 +87.2% 01 Jan 2021 31 Dec 2021 10-K 02 Mar 2023
2020 -$105 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.